KT

Komal Dadasaheb Thorat - Profile

Komal Dadasaheb Thorat, Director and Designated Partner, with 4 companies.

About Komal Dadasaheb Thorat

Komal Dadasaheb Thorat has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Bravax Pharma Private Limited and Dasp Briquettes Industries Llp. Formerly with 2 companies, such as Bravax Pharma Private Limited and Fealty Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.

Current Companies 2
Past Companies 2
Total Affiliations 4
Oldest Company Age 4
Companies Associated with Komal Dadasaheb Thorat
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Komal Dadasaheb Thorat?

Komal Dadasaheb Thorat has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Bravax Pharma Private Limited and Dasp Briquettes Industries Llp. Formerly with 2 companies, such as Bravax Pharma Private Limited and Fealty Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.

What is Komal Dadasaheb Thorat's role in current companies?

Komal Dadasaheb Thorat is associated with 2 companies as Director and Designated Partner.

What industries does Komal Dadasaheb Thorat specialize in?

Komal Dadasaheb Thorat has expertise in General Business.

How many years of experience does Komal Dadasaheb Thorat have?

Komal Dadasaheb Thorat has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available